Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/41614164

Antonios Kolocouris; Bin Tan; George Lambrinidis; Guangjin Fan; Haozhou Tan; Jun Wang; Kan Li; Kyriakos Georgiou; Navita Kohaal; Xiang Chi; Xueying Liang; Xufang Deng; Yu Chen; Zhengjun Cai

Jan 30, 2026